PRIMA

subretinal

Inventor Daniel Palanker

Home InstitutionStanford University

Commercial Partners Pixium Vision, Science Corporation

Regulatory Review

WarningWarningThis profile has not been verified yet. Information presented here may thus be incomplete or inaccurate.WarningWarning

The Prima System is intended to partially replace the normal physiological function of the eyes photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve.

Implant Timeline

  • FDA Approval

Device Specifications

  • Number of electrodes: 378

Clinical Trials